ReviewCurrent oncology (Toronto, Ont.)2023

Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective.

Jan-Willem Henning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.